Aethlon Medical Inc
Research Aethlon Medical Inc (AEMD) on Bullrun: market cap USD 2.89M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerAEMD
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Market capUSD 2.89M
- Financial periodFY2026
- RevenueUSD 0
- Net income-USD 7.15M
- Free cash flow-USD 7.00M
Valuation Snapshot
latest market cap is USD 2.89M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | USD 0 | -USD 7.15M | -USD 7.00M | n/a | -10.61 | USD 5.03M | USD 336.72K | USD 4.89M |
| FY2025 | USD 0 | -USD 13.39M | -USD 7.65M | n/a | -8.58 | USD 5.50M | USD 649.75K | USD 5.12M |
| FY2024 | USD 0 | -USD 12.21M | -USD 10.38M | n/a | -38.87 | USD 5.44M | USD 940.32K | USD 5.77M |
| FY2023 | USD 574.25K | -USD 12.03M | -USD 11.45M | n/a | -5.86 | USD 14.53M | USD 1.21M | USD 15.06M |
| FY2022 | USD 294.17K | -USD 10.42M | -USD 10.12M | n/a | -0.71 | USD 17.07M | USD 729.41K | USD 16.99M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-09 | USD 2.89M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 2.69M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 12.03M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 5.47M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 6.43M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 28.72M | n/a | n/a | n/a |
About Aethlon Medical Inc
Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation, and other disease states. The company was founded in 1984 and is based in San Diego, California.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Aethlon Medical Inc's market cap?
Aethlon Medical Inc's market capitalization is USD 2.89M.
What does Aethlon Medical Inc do?
Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation, and other disease states. The company was founded in 1984 and is based in San Diego, California.